Parkinson's Flashcards
Parkinson’s Pathophys
Neurodegenerative disorder of the extrapyramidal system associated with disruption of neurotransmission in the striatum
Imbalance in the balance of acetylcholine and dopamine results in degeneration of neurons that supply dopamine to the striatum
> without adequate dopamine, acetylcholine causes excessive stimulation of neurons that release gamma-aminobutyric acid
Therapeutic Goals of Parkinson’s
- Improve ADLS
- Ideally treatment would reverse but this does not exist
Drug Selection for Parkinson’s: Initial Treatment
Mild Symptoms: MAO-B inhibitors (selegiline, rasagiline)
More Severe Symptoms: Levodopa (combined with carbidopa) as dopamine replacement or dopamine agonist
Parkinson’s: Management of Fluctuations
- Drug-Induced Dyskinesias
Involuntary Movements: often involves hyperkinetic movement including chorea, dystonia and athetosis
Parkinson’s Treatment: “Off Times”
- Can be reduced with dopamine agonists, COMT inhibitors, and MAO-B inhibitors
Improve Motor Function: LEVODOPA
Improve drug induced dyskinesia: DOPAMINE AGONIST
Parkinson’s Treatment
- ON OFF
> Freezing - WEARING OFF
- ON OFF: switch between mobility and immobility
> Freezing: gait episodes: often when subtherapeutic - WEARING OFF: worsening in motor function and unpredictable motor function
Levodopa
- Combo with?
- How long for effectiveness takes place?
- How long after taking before not effective?
Food implications
- Only given in combo with carbidopa
- HIGHLY effective
- SEVERAL MONTHS OF TREATMENT NEEDED FOR FULL THERAPEUTIC EFFECT
- SX WELL CONTROLLED FOR FIRST 2 YEARS
- RETURN TO PRETREATMENT STATE AT END OF 5 YEARS
- Orally administered; rapidly absorbed in the small intestine
> food delays absorption
> neutral amino acids compete with levodopa for intestinal absorption
> high protein foods reduce therapeutic effects
Gradual Loss/Wearing Off of Levodopa
3 THINGS TO MINIMIZE WEARING OFF
- Develops near the end of dosing interval and indicates that drug levels have declined past subtherapeutic value
Three ways to be minimized:
1. Shortening dosing interval (give more frequently)
2. Giving a drug that prolongs levodopa’s half-life (ie entacapone)
» WHAT CLASS OF DRUG IS THIS? (COMT)
» Inhibits metabolism of Levodopa in periphery
3. Giving direct-acting dopamine agonist
» pramipexole and ropinirole and rotigimine
Adverse Effect of Levodopa
N/V
- Activation of dopamine receptors trigger medulla
- Treatment:
> low initial doses and with food (by lowering absorption)
> Giving carbidopa (without levodopa) can reduce n/v
Postural Hypotension - Treatment > Increase intake of salt and water > use the lowest dose necessary > limit alpha antagonist (-osins)
CNS Effects:
- Psychosis, hallucinations, vivid dreams, nightmares, paranoia, impulse control problems, behavioral changes (alcohol abuse, binge eating, gambling, hypersexual)
- Caused by activation of dopamine receptors
- Treatment:
> lower the dose
Dyskinesia’s from Levodopa
- Develop just before or after optimal dosage is achieved
- Managed in three ways
1. Reduce levodopa
2. Amantadine or dopamine agonist
» why would these help??? bc they block the dopamine?
- Surgery or electrical stimulation
Levodopa Adverse Effects
- Darkens sweat and urine
- Activates malignant melanoma: Important to perform careful skin inspections
Dopamine Agonists
- Compared to Levodopa: > less effective > not dependent on enzyme conversion to be active > does not compete with dietary proteins > lower incidence of response failure > less likely to cause dyskinesias
Two Types:
- Derivatives of ergot
- Nonergot derivatives
Nonergot Derivative Dopamine Agonist
Pramipexole & Ropinirole (and also rotigotine)
- Can be used alone in early therapy or as adjunct to levodopa in worsening disease
- Can be used as first line in younger pts ( <50yo )
- Can be added to levodopa for reduced off time and improve dyskinesia caused by levodopa
- Also used in restless leg syndrome
> Max benefits take several weeks
Not as effective as levodopa
Pramipexole Adverse Effects
Nonergot Derivative Dopamine Agonist
Monotherapy:
- nausea, dizziness, daytime somnolence, insomnia, constipation, weakness, hallucinations
Combined:
- orthostatic hypotension, dyskinesia, increased hallucinations
- Rarely: sleep attacks, gambling, self-rewarding behaviors
» WHAT OTHER DRUG HAS THIS SAME EFFECT? - levodopa?? and ropinirole
Rotigotine
Nonergot Dopamine Agonist
- Transdermal
- Management of PD from early to advanced stages
- Management of mod-sev primary restless leg syndrome
- Most common adverse effects: CNS
- Other side effects: orthostatic hypotension, peripheral edema, n/a, skin reaction at transdermal site, hyperhidrosis